Sales rose 6% for L’Oréal in the first nine months ending September 2024 with sales reaching $34.9 billion. For the third quarter, sales rose 3.4%.

“We delivered solid growth of +6% in the first nine months, well-balanced between value and volume, despite multiple turbulences that have negatively impacted our third quarter,” said CEO Nicolas Hieronimus.

Professional Products at Nine Months

Outperforming the global professional market, the division grew across all regions: in developed markets, North Asia—notably China, as well as emerging markets—including GCC, Brazil and Mexico.

Professional products continued to advance thanks to its omnichannel strategy, with strong acceleration in both e-commerce and selective distribution.

In the haircare market, growth was fueled by Kérastase with the launch of Première and Elixir Ultime, as well as L’Oréal Professionnel thanks to the continued strength of Absolute Repair Molecular.

In hair color, Shades EQ by Redken, iNOA, as well as Dia Color by L’Oréal Professionnel maintained their performance.

Consumer Products at Nine Months

With positive growth from volume, as well as price and mix, the division continued to conquer new consumers around the world.

By region, Europe remained a strong growth driver – as did key emerging markets like Brazil, Mexico and India. In China, where L’Oréal Paris is the number one mass brand, the division continued to suffer from low consumer demand. North America was impacted by the ongoing softness in the makeup category; many innovations have been launched only recently and will benefit mostly 2025.

All categories grew, fueled by strong innovations, according to the company. Haircare was the fastest growing category, led by L’Oréal Paris Elvive as the success of newly launched Glycolic Gloss complemented the franchise’s top-selling pillars. Makeup grew, driven by L’Oréal Paris Panorama mascara and the promising start of NYX Professional Makeup’s Buttermelt and Maybelline New York’s Teddy Tint in Southeast Asia. In skincare, Garnier confirmed the success of Vitamin C Daily UV fluids; L’Oréal Paris says it’s building an anti-dark-spot offer with Bright Reveal and Glycolic Bright; Mixa saw strong growth as it continued its European roll-out. The democratization and premiumization strategy were in action in hair color, with Garnier simultaneously supporting its premium Good range and launching its most accessible innovation ever, Color Sensation.

Luxe Division at Nine Months

In North America as well as emerging markets, the division maintained double-digit growth, while in Europe it remained firmly dynamic. In mainland China and Travel Retail Asia, where the beauty market continued to decline, the division outperformed, further reinforcing its leadership. In Japan, L’Oréal Luxe continued to grow in double digits in a market that remained dynamic.

L’Oréal Luxe maintained its double-digit pace. With its portfolio of complementary brands, officials said the division is uniquely positioned to fulfil all fragrance aspirations – and all segments contributed to the growth: the couture brands continued their stellar success sustained by their powerful pillars like Yves Saint Laurent Libre, Valentino Born in Roma or Prada Paradoxe; the super-premium collections like Maison Margiela Replica or Armani Privé continued to advance strongly; brands such as Azzaro and Viktor&Rolf made significant contributions to growth.

Makeup continued its comeback with a strong Yves Saint Laurent posting double-digit growth in all regions. Prada pursued its ambitious expansion, and Valentino gained momentum with the launch of its newest innovation Spike Valentino.

Dermatological Beauty at Nine Months

Adjusted for the $61.43 million due to last year’s Vichy plant insurance benefit in the third quarter of 2023, the division grew +12.6% like for like in the first nine months. It continued to significantly outperform the dermocosmetics market, which has been slowing, impacted primarily by the US and a lower contribution from valorization.

Developed and emerging markets both advanced in double digits, with significant expansion in SAPMENA-SSA, and substantial market outperformance in mainland China, the US and Europe.

By brand, La Roche-Posay led the growth, driven by the successful launch of Mela B3, a breakthrough innovation addressing pigmentation issues with the multi-patented Melasyl molecule. CeraVe continued to outpace the market across all regions; nearly half of its sales now come from outside the US. Vichy delivered double-digit growth, bolstered by the success of its Dercos haircare line. SkinCeuticals accelerated, boosted by the introduction of P-Tiox, a professional anti-wrinkle serum.